Omnicell Tops Its Own Q3 Guidance, Lifts FY2026 EBITDA and EPS Outlook
OMCL sits 26% above its 52-week low of $29.09.
Summary
Omnicell reported Q3 2026 revenue of $307.9M and non-GAAP EPS of $0.58, both above its prior guidance range, and raised full-year 2026 non-GAAP EBITDA and EPS guidance. Revenue still fell 1% year over year, so the beat came from service margins and cost discipline rather than growth.
Key Events · Earnings and Guidance · OMCL
-
Q3 Results Beat Prior Guidance
Total revenues of $307.9M and non-GAAP EPS of $0.58 came in above the high end of the previously provided guidance range, with GAAP net income of $11.0M ($0.24 per diluted share) versus $5.5M ($0.12) a year earlier.
-
FY2026 EBITDA and EPS Guidance Raised
Full-year 2026 non-GAAP EBITDA guidance was increased to $187M-$193M and non-GAAP EPS to $2.48-$2.56, while total revenue guidance was tightened to $1.225B-$1.231B.
-
Margins Drove the Beat, Not Growth
Revenue fell 1% year over year to $307.9M from $310.6M as product revenue declined to $173.1M from $177.5M; service gross margin expanded to 46.7% from 40.4% and non-GAAP operating margin rose to 10.3% from 8.8%.
-
Bookings Range Left Wide
Full-year 2026 product bookings guidance was reiterated at $425M-$560M and annual recurring revenue tightened to $660M-$670M, leaving a wide spread on capital equipment demand.
Analysis · OMCL · Technology
Both revenue and profitability came in above the high end of the company's prior guidance range, and management used the beat to raise full-year 2026 non-GAAP EBITDA to $187M-$193M and non-GAAP EPS to $2.48-$2.56. What matters here is the quality of the beat rather than the top line: revenue actually slipped 1% year over year to $307.9M, yet service gross margin expanded to 46.7% from 40.4% and operating expenses fell, lifting GAAP operating income to $14.9M from $8.2M. That is margin and cost execution, not demand acceleration — product revenue declined to $173.1M from $177.5M. The balance sheet is comfortable, with $314.9M of cash against $168.5M of convertible notes and an undrawn $350M revolver, so this is an operating story rather than a liquidity one. The open question is the top line: full-year revenue guidance was tightened to $1.225B-$1.231B and product bookings were only reiterated at $425M-$560M, a wide range that leaves the 2027 setup unresolved.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OMCL was trading at $36.56 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $29.09 to $55.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.